MAY
4
Back by Popular Demand - KRAS G12C Mutation: An Emerging Biomarker for NSCLC Sponsored by Amgen®
5
Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care: HHS/ASPR COVID-19 Therapeutics program
6
Myasthenia Gravis: How antibody testing helps you in the management of your patient
Give Us Your Feedback
Publication: Multiple pigmented trichoblastomas, sebaceous carcinoma and syringocystadenoma papilliferum arising within a nevus sebaceous.